Compare Lustrum:Nissui Pharmaceutical Co.,Ltd.:4550

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nissui Pharmaceutical Co.,Ltd. Go to web site 4550 Medicals 東証プライム March 1, 2000 1990.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Nissui Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2022年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2021年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2019年3月期 Nissui Pharmaceutical Co.,Ltd. Balance Sheet 2018年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Cash and Cash Equivalents
(Percent)
4,807up
(13.0%)up
4,461up
(12.5%)up
3,462up
(9.8%)up
2,401down
(6.7%)down
7,565
(21.1%)
Other Current AssetsHelp
(Percent)
27,141up
(73.5%)up
25,923up
(72.4%)up
25,041down
(71.1%)down
27,005up
(75.2%)up
21,401
(59.8%)
Tangible Fixed AssetsHelp
(Percent)
3,207down
(8.7%)down
3,274down
(9.1%)down
4,962up
(14.1%)up
3,848down
(10.7%)down
3,893
(10.9%)
Intangible Fixed AssetHelp
(Percent)
114up
(0.3%)up
77down
(0.2%)down
101down
(0.3%)down
109down
(0.3%)down
111
(0.3%)
Investments and OthersHelp
(Percent)
1,655down
(4.5%)down
2,066up
(5.8%)up
1,637down
(4.7%)down
2,538down
(7.1%)down
2,839
(7.9%)
Total AssetsHelp
(Percent)
36,924
(100%)
35,801
(100%)
35,203
(100%)
35,901
(100%)
35,809
(100%)
Total Current LiabilitiesHelp
(Percent)
4,229up
(11.5%)up
3,321up
(9.3%)up
3,026down
(8.6%)up
3,044up
(8.5%)up
2,767
(7.7%)
Total Long-term LiabilitiesHelp
(Percent)
90up
(0.2%)up
8up
(0.0%)up
1down
(0.0%)down
30down
(0.1%)down
68
(0.2%)
Shareholder's EquityHelp
(Percent)
32,605up
(88.3%)down
32,472up
(90.7%)down
32,176down
(91.4%)down
32,827down
(91.4%)down
32,974
(92.1%)
Total LiabilitiesHelp
(Percent)
36,924
(100%)
35,801
(100%)
35,203
(100%)
35,901
(100%)
35,809
(100%)

Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2019年3月期 Nissui Pharmaceutical Co.,Ltd. Profit and Loss Account 2018年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Amount of Sales
(Percent)
16,657
(100%)
11,971
(100%)
12,773
(100%)
12,549
(100%)
12,329
(100%)
Total Sales
(Percent)
16,657
(100%)
11,971
(100%)
12,773
(100%)
12,549
(100%)
12,329
(100%)
Cost of SalesHelp
(Percent)
11,399up
(68.4%)up
7,871up
(65.8%)up
7,047up
(55.2%)up
6,791up
(54.1%)up
6,476
(52.5%)
Other Costs and RevenueHelp 4,112up
(24.7%)down
3,444down
(28.8%)down
5,324up
(41.7%)up
4,973up
(39.6%)up
4,677
(37.9%)
Total CostsHelp 15,511 11,315 12,371 11,764 11,153
Net RevenueHelp 5,258up
(31.6%)down
4,100down
(34.2%)down
5,726down
(44.8%)down
5,758down
(45.9%)down
5,853
(47.5%)
Earnings Before TaxHelp 1,649up
(9.9%)up
943up
(7.9%)up
642down
(5.0%)down
1,382down
(11.0%)down
1,691
(13.7%)
Net IncomeHelp 1,146up
(6.9%)up
656up
(5.5%)up
402down
(3.1%)down
785down
(6.3%)down
1,176
(9.5%)
当期純利益 1,146 656 402 785 1,176

Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2019年3月期 Nissui Pharmaceutical Co.,Ltd. Cash Flow Statement 2018年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Operating Cash Flow(OFC)Help
(Percent)
1,007up
(73.0%)up
505down
(35.0%)down
1,495up
(52.1%)up
1,363up
(11.9%)down
865
(70.5%)
Investing Cash Flow(ICF)Help
(Percent)
361down
(26.2%)down
938up
(65.0%)up
-1,940up
(-67.6%)up
-10,527down
(-91.9%)down
362
(29.5%)
Financing Cash FlowHelp
(Percent)
-1,010down
(-73.2%)down
-476up
(-33.0%)down
-931down
(-32.4%)down
-930down
(-8.1%)up
-929
(-75.7%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
11
(0.8%)
0
-
0
-
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn 369down
(26.8%)down
967up
(67.0%)up
-1,376up
(-47.9%)up
-10,094down
(-88.1%)down
298
(24.3%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nissui Pharmaceutical Co.,Ltd.

Company where related level is highHelp

NANO MRNA Co., Ltd.
GNI Group Ltd.
Toyama Chemical Co.,Ltd.
AnGes,Inc.
ASKA Pharmaceutical Holdings Co., Ltd.
Nxera Pharma Co., Ltd.
MIZUHO MEDY CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
Takeda Pharmaceutical Company Limited
Renascience Inc.